Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
14.30
-0.11 (-0.76%)
At close: Feb 27, 2026, 4:00 PM EST
14.58
+0.28 (1.96%)
After-hours: Feb 27, 2026, 6:03 PM EST
Enanta Pharmaceuticals Employees
Enanta Pharmaceuticals had 120 employees as of September 30, 2025. The number of employees decreased by 11 or -8.40% compared to the previous year.
Employees
120
Change (1Y)
-11
Growth (1Y)
-8.40%
Revenue / Employee
$558,167
Profits / Employee
-$596,142
Market Cap
414.98M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| REGENXBIO | 353 |
| Entrada Therapeutics | 183 |
| Absci | 157 |
| Niagen Bioscience | 104 |
| PepGen | 57 |
| PureTech Health | 56 |
| Tectonic Therapeutic | 51 |
| Anavex Life Sciences | 34 |
ENTA News
- 18 days ago - Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the Treatment of Type 2 Immune Diseases, at the 2026 AAAAI Annual Meeting - Business Wire
- 19 days ago - Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025 - Business Wire
- 6 weeks ago - Enanta Pharmaceuticals, Inc. (ENTA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook - Business Wire
- 7 weeks ago - Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 3 months ago - Enanta: Maintaining Buy Rating Based On Zelicapavir Potential In RSV Development - Seeking Alpha
- 3 months ago - Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2025 - Business Wire
- 4 months ago - Enanta Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire